+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Eluting Stent"

From
From
From
From
Bioresorbable Stents - Global Strategic Business Report - Product Thumbnail Image

Bioresorbable Stents - Global Strategic Business Report

  • Report
  • April 2024
  • 125 Pages
  • Global
From
Coronary Stents - Global Strategic Business Report - Product Thumbnail Image

Coronary Stents - Global Strategic Business Report

  • Report
  • April 2024
  • 342 Pages
  • Global
From
Vascular Stent Global Market Report 2024 - Product Thumbnail Image

Vascular Stent Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Bifurcation Lesions Global Market Report 2024 - Product Thumbnail Image

Bifurcation Lesions Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Intracranial Stents Global Market Report 2024 - Product Thumbnail Image

Intracranial Stents Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Bioabsorbable Stents Global Market Report 2024 - Product Thumbnail Image

Bioabsorbable Stents Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Drug Eluting Stent (DES) market is a subset of the drug delivery market. DES are medical devices used to treat coronary artery disease. They are inserted into the artery and release a drug over time to prevent the artery from narrowing again. The DES market has grown in recent years due to the increasing prevalence of cardiovascular diseases and the need for more effective treatments. The DES market is expected to continue to grow as new technologies are developed and the demand for more effective treatments increases. Some of the major players in the DES market include Abbott, Boston Scientific, Medtronic, Biotronik, and Terumo. Show Less Read more